M
Morten Ruhwald
Researcher at Statens Serum Institut
Publications - 130
Citations - 4965
Morten Ruhwald is an academic researcher from Statens Serum Institut. The author has contributed to research in topics: Tuberculosis & Mycobacterium tuberculosis. The author has an hindex of 33, co-authored 106 publications receiving 4198 citations. Previous affiliations of Morten Ruhwald include University of Copenhagen & Foundation for Innovative New Diagnostics.
Papers
More filters
Journal ArticleDOI
Towards tuberculosis elimination: an action framework for low-incidence countries
Knut Lönnroth,Giovanni Battista Migliori,Ibrahim Abubakar,Lia D'Ambrosio,Gerard De Vries,Roland Diel,Paul Douglas,Dennis Falzon,Marc Andre Gaudreau,Delia Goletti,Edilberto R. González Ochoa,Philip A. LoBue,Alberto Matteelli,Howard Njoo,Ivan Solovic,Alistair Story,Tamara Tayeb,Marieke J. van der Werf,Diana Weil,Jean-Pierre Zellweger,Mohamed Abdel Aziz,Mohamed R.M. Al Lawati,Stefano Aliberti,Wouter Arrazola de Oñate,Draurio Barreira,Vineet Bhatia,Francesco Blasi,Amy Bloom,Judith Bruchfeld,Francesco Castelli,Rosella Centis,Daniel Chemtob,Daniela Maria Cirillo,Alberto Colorado,Andrei Dadu,Ulf R Dahle,Laura De Paoli,Hannah Monica Yesudian Dias,Raquel Duarte,Lanfranco Fattorini,Mina Gaga,Haileyesus Getahun,Philippe Glaziou,Lasha Goguadze,Mirtha del Granado,Walter Haas,Asko Järvinen,Geun Yong Kwon,Davide Mosca,Payam Nahid,Nobuyuki Nishikiori,I. Noguer,Joan O'Donnell,Analita Pace-Asciak,Maria Grazia Pompa,Gilda Popescu,Carlos Robalo Cordeiro,Karin Rønning,Morten Ruhwald,Jean-Paul Sculier,Aleksandar Simunovic,Alison Smith-Palmer,Giovanni Sotgiu,Giorgia Sulis,Carlos A. Torres-Duque,Kazunori Umeki,Mukund Uplekar,Catharina Van Weezenbeek,Tuula Vasankari,Robert J. Vitillo,Constantia Voniatis,Maryse Wanlin,Mario C. Raviglione +72 more
TL;DR: An action framework for countries with low tuberculosis (TB) incidence sets out priority interventions required for these countries to progress first towards “pre-elimination” and eventually the elimination of TB as a public health problem.
Journal ArticleDOI
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis
Roland Diel,Delia Goletti,Giovanni Ferrara,Graham H. Bothamley,Daniela Maria Cirillo,Beate Kampmann,Christoph Lange,Monica Losi,Roumiana Markova,Giovanni Battista Migliori,Albert Nienhaus,Morten Ruhwald,Dirk Wagner,Jean-Pierre Zellweger,Emma Huitric,Andreas Sandgren,Davide Manissero +16 more
TL;DR: IGRAs may have a relative advantage over the TST in detecting LTBI and allow the exclusion of M. tuberculosis infection with higher reliability.
Journal ArticleDOI
Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ test
TL;DR: The QFT-IT test may indeed be a useful test for HIV positive individuals, but in severely immunocompromised, the test may be impaired by T-cell anergy.
Journal ArticleDOI
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.
Jaap T. van Dissel,Simone A. Joosten,Søren T. Hoff,Darius Soonawala,Corine Prins,David A. Hokey,Dawn M. O’Dee,Andrew Graves,Birgit Thierry-Carstensen,Lars Vibe Andreasen,Morten Ruhwald,Adriëtte W. de Visser,Else Marie Agger,Tom H. M. Ottenhoff,Ingrid Kromann,Peter Andersen +15 more
TL;DR: Results show that CAF01 is a safe and tolerable, Th1-inducing adjuvant for human TB vaccination trials and for vaccination studies in general where cellular immunity is required.
Journal ArticleDOI
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
Morten Ruhwald,T. Bodmer,C. Maier,M. Jepsen,Maya Bonde Haaland,Jesper Eugen-Olsen,Pernille Ravn +6 more
TL;DR: In this paper, the potential of diagnostic tests based on interferon-gamma inducible protein (IP)-10 and monocyte chemotactic protein (MCP)-2, and compare the performance with the QuantiFERON TB Gold In-Tube (QFT-IT; Cellestis, Carnagie, Australia) test.